ID   NP-2/CD4/FPRL1
AC   CVCL_A6US
SY   NP-2/CD4/EcoVR/FPRL1
DR   cancercelllines; CVCL_A6US
DR   RCB; RCB5311
DR   Wikidata; Q107116576
RX   PubMed=18577234;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3827; FPR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R18 ! NP-2/CD4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
RX   PubMed=18577234; DOI=10.1186/1742-4690-5-52; PMCID=PMC2453146;
RA   Shimizu N., Tanaka A., Mori T., Ohtsuki T., Hoque A., Jinno-Oue A.,
RA   Apichartpiyakul C., Kusagawa S., Takebe Y., Hoshino H.;
RT   "A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for
RT   primary isolates of human immunodeficiency virus.";
RL   Retrovirology 5:52.1-52.14(2008).
//